MedPath

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

Not Applicable
Completed
Conditions
Eosinophilic Esophagitis
Interventions
First Posted Date
2009-08-18
Last Posted Date
2012-11-06
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
25
Registration Number
NCT00961233
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

Phase 2
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2009-08-17
Last Posted Date
2016-06-06
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
80
Registration Number
NCT00959894
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

🇺🇸

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

🇺🇸

Carolinas Medical Center, Charlotte, North Carolina, United States

Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program

Phase 2
Completed
Conditions
Acquired Immunodeficiency Syndrome
HIV Infections
Interventions
Behavioral: Tailored Information Program for Safer Sex
First Posted Date
2009-07-28
Last Posted Date
2013-11-15
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
274
Registration Number
NCT00947947
Locations
🇺🇸

Specialty Clinic, Louisville Metro Health Department, Louisville, Kentucky, United States

Treatment for Periodontal Disease in Dialysis Patients

Not Applicable
Completed
Conditions
Periodontal Disease
Interventions
Procedure: Periodontal Scaling and Root Planing
First Posted Date
2009-07-13
Last Posted Date
2012-05-07
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
60
Registration Number
NCT00937976
Locations
🇺🇸

GO Health Center, School of Dentistry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States

Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease

Phase 2
Completed
Conditions
Cystic Fibrosis
Interventions
Drug: Placebo first
Drug: Lucinactant first
First Posted Date
2009-07-08
Last Posted Date
2017-03-13
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
16
Registration Number
NCT00934362
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Burn Healing and Analgesia With Propranolol

Phase 2
Completed
Conditions
Pain
Burns
Interventions
First Posted Date
2009-07-08
Last Posted Date
2017-11-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
45
Registration Number
NCT00934947
Locations
🇺🇸

Washington Hospital Center, Washington, D.C., District of Columbia, United States

🇺🇸

North Carolina Jaycee Burn Center, Chapel Hill, North Carolina, United States

🇺🇸

Crozer Chester Medical Center, Upland, Pennsylvania, United States

and more 1 locations

Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy

Phase 1
Completed
Conditions
Peanut Hypersensitivity
Interventions
First Posted Date
2009-07-03
Last Posted Date
2018-03-01
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
13
Registration Number
NCT00932282
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study

Phase 2
Completed
Conditions
Food Hypersensitivity
Interventions
First Posted Date
2009-07-03
Last Posted Date
2018-05-24
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
37
Registration Number
NCT00932828
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

UCAN: Uniting Couples in the Treatment of Anorexia Nervosa

Not Applicable
Completed
Conditions
Anorexia Nervosa
Interventions
Behavioral: CBCT
Behavioral: Family Supportive Therapy
First Posted Date
2009-06-25
Last Posted Date
2012-11-09
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
40
Registration Number
NCT00928109
Locations
🇺🇸

UNC Chapel Hill, Chapel Hill, North Carolina, United States

Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)

Phase 4
Completed
Conditions
Premenstrual Dysphoric Disorder
Interventions
Drug: Continuous OC (EE/DROS)
Drug: Intermittent OC (EE/DROS)
Drug: placebo
First Posted Date
2009-06-24
Last Posted Date
2016-08-24
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
67
Registration Number
NCT00927095
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath